CycloLab awarded by 2021 Innovation Grand Prize
The Hungarian Association of Innovation awarded CycloLab with this prestigious prize due to its meaningful and very profitable innovation concerning
Author: CycloLab Ltd.
CycloLab appoints new leaders in key positions
As CycloLab continues to expand its workforce both in the production and the R&D arms of the company, two new
Press Release – Development of Autophagy Inducing Cyclodextrin Derivatives for Aging-associated Diseases
CycloLab Cyclodextrin R&D Ltd. proudly announces winning of a national grant about the development of cyclodextrin-dervatives for autophagy-associated neurodegenerative diseases.
Cyclodextrin Phosphates
In order to develop cyclodextrin derivatives having improved aqueous solubility, high solubilizing power, and low accumulation upon longer administration charged
Nanoaggregation on command
ScienceDaily reported on the effect of cyclodextrins as parts of synthetic receptors on the aggregation of proteins, recently published by
Annual National Niemann Pick Disease Foundation Conference
Among several lectures useful for the families with member(s) suffering in rare diseases the ongoing clinical trials for NPC patients